Annual report pursuant to Section 13 and 15(d)

Statements of Shareholders' Equity (Deficit)

v3.21.1
Statements of Shareholders' Equity (Deficit) - USD ($)
Series C Preferred Stock [Member]
Series D Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2018 $ 99 $ 20,152,995 $ (39,112,401) $ (18,959,307)
Balance, shares at Dec. 31, 2018 987,087      
Issuance of common stock upon exercise of Series A Warrants, net of cost $ 4 2,172,676 2,172,680
Issuance of common stock upon exercise of Series A Warrants, net of cost, shares 42,412      
Issuance of common stock as inducement to exercise Series A Warrants $ 5 (5) 0
Issuance of common stock as inducement to exercise Series A Warrants, shares 50,894      
Issuance of common stock upon exercise of Series B warrants $ 162 14,584,209 14,584,371
Issuance of common stock upon exercise of Series B warrants, shares 1,619,222      
Issuance of common stock upon exercise of Placement Agent Warrants 16,818 16,818
Issuance of common stock upon exercise of Placement Agent Warrants, shares 400      
Issuance of Series C preferred Stock upon exchange of Series A and Series B warrants 3,671,024 3,671,024
Issuance of Series C preferred Stock upon exchange of Series A and Series B warrants, shares 4,268      
Issuance of common stock upon Series C preferred conversion $ 30 (30)
Issuance of common stock upon Series C preferred conversion, shares (3,000) 300,000      
Stock based compensation expense 336,637 336,637
Warrants issued in connection with convertible notes payable 595,000 595,000
Issuance of common stock upon conversion of convertible notes payable $ 30 293,724 293,754
Issuance of common stock upon conversion of convertible notes payable, shares 300,000      
Issuance of Series D Preferred Stock upon exchange of convertible note payable $ 4,816,485 4,816,485
Issuance of Series D Preferred Stock upon exchange of convertible note payable, shares 5,775      
Net loss (4,300,969) (4,300,969)
Balance at Dec. 31, 2019 $ 4,816,485 $ 330 41,823,048 (43,413,370) 3,226,493
Balance, shares at Dec. 31, 2019 1,268 5,775 3,300,015      
Issuance of common stock upon Series C preferred conversion $ 13 (13)
Issuance of common stock upon Series C preferred conversion, shares (1,268) 3,563 126,800      
Stock based compensation expense 425,264 425,264
Issuance of common stock upon conversion of convertible notes payable $ 340 2,905,794 2,906,134
Issuance of common stock upon conversion of convertible notes payable, shares 3,400,000      
Redemption of Series D Preferred Stock $ (1,844,860) (1,295,294) (3,140,154)
Redemption of Series D Preferred Stock, shares (2,212)      
Conversion of Series D Preferred Stock $ (2,971,625) $ 314 2,971,311
Conversion of Series D Preferred Stock, shares (3,563) 3,141,426      
Exchange of Series A and B Notes to preferred and common stock $ 185 1,716,604 1,716,789
Exchange of Series A and B Notes to preferred and common stock, shares 1,850,000      
Issuance of common stock and warrants $ 2,930 30,984,819 30,987,749
Issuance of common stock and warrants, net of issuance costs, shares 29,299,200      
Issuance of common stock for services $ 36 572,364 572,400
Issuance of common stock for services, shares 360,000      
Issuance of common stock upon exercise of warrants $ 244 (244)
Issuance of common stock upon exercise of warrants, shares 2,441,390      
Net loss (17,348,622) (17,348,622)
Balance at Dec. 31, 2020 $ 4,392 $ 80,103,653 $ (60,761,992) $ 19,346,053
Balance, shares at Dec. 31, 2020 43,918,831